CLINICAL_TRIALS
trial_result
· 2016-08-08
Clinical Trial Update: Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer [Phase 2]
Summary
A Phase 2 trial evaluating neoadjuvant hormonal therapy plus docetaxel for node-positive prostate cancer has completed enrollment and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-08-08